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Abstract
Background: The National Institute for Health Research (NIHR) was established in 2006 with the aim of creating an
applied health research system embedded within the English National Health Service (NHS). NIHR sought to
implement an approach for monitoring its performance that effectively linked early indicators of performance with
longer-term research impacts. We attempted to develop and apply a conceptual framework for defining
appropriate key performance indicators for NIHR.
Method: Following a review of relevant literature, a conceptual framework for defining performance indicators for
NIHR was developed, based on a hybridisation of the logic model and balanced scorecard approaches. This
framework was validated through interviews with key NIHR stakeholders and a pilot in one division of NIHR, before
being refined and applied more widely. Indicators were then selected and aggregated to create a basket of
indicators aligned to NIHR’s strategic goals, which could be reported to NIHR’s leadership team on a quarterly basis
via an oversight dashboard.
Results: Senior health research system managers and practitioners endorsed the conceptual framework developed
and reported satisfaction with the breadth and balance of indicators selected for reporting.
Conclusions: The use of the hybrid conceptual framework provides a pragmatic approach to defining
performance indicators that are aligned to the strategic aims of a health research system. The particular strength of
this framework is its capacity to provide an empirical link, over time, between upstream activities of a health
research system and its long-term strategic objectives.
Background
The evolution of national health research systems
Over the last twenty years there has been a greater than
five-fold increase in spending on health research glob-
ally, from an estimated US$30bn in 1986 [1] to over US
$160bn in 2005 [2]. A substantial proportion of this
funding has come from public sector sources (49% in
2005) [2], that is to say from governments and publicly
funded charities. Along with this increased expenditure,
there has been a shift in the thinking of governments
regarding the role of Government in supporting health
research. First, the concept of ‘essential national health
research’ (ENHR) has gained increasing acceptance in
health research policy circles following its proposal in
1990 by the Commission on Health Research for Devel-
opment [3]. ENHR was originally proposed as a means
of defining a research agenda focused on the priority
health needs of a country, thereby explicitly tying the
actions of a nation’s health research resources to the
goals of its health system. This coupling of national
health research priorities to national health systems sub-
sequently led to the explicit recognition of the existence
and importance of ‘national health research systems’,a
term marshalled most prominently by the WHO Inter-
national Workshop on National Health Research Sys-
tems, held in Thailand in 2001. This workshop defined
an a t i o n a lh e a l t hr e s e a r c hs y s t e ma s“a system for plan-
ning, coordinating, monitoring and managing health
research resources and activities; and for promoting
research for effective and equitable national health
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assumption that improved integration of health research
activity into a cohesively managed national system will
improve the performance of that system in meeting
national health research priorities.
Performance monitoring and evaluation
The distinction between performance monitoring and
evaluation is an important one. Performance monitoring
can be defined as “a continuous process of collecting
and analyzing data to compare how well a project, pro-
gram, or policy is being implemented against expected
results” (OECD 2002) [5]. The central activity of perfor-
mance monitoring is the collation of data to facilitate
the reporting of performance indicators, that is to say
quantitative or qualitative variables that allow for the
identification of changes produced by a specific inter-
vention, activity, project, programme or policy (OECD
2002) [5]. Performance monitoring is an integral compo-
nent of performance management, whereby manage-
ment control systems respond to performance
information in a manner conducive to the improvement
of performance [6]. Evaluation, on the other hand, can
be defined as the “judgement of interventions according
to their results, impacts and needs they aim to satisfy”
(OECD 2002) [5]. In contrast to performance monitor-
ing, evaluation (particularly in a public sector context) is
often understood to be concerned with summative
assessments of the success or failure of specific pro-
grammes and projects in achieving their stated goals.
Effective performance management requires managers
to have access to performance information that gives a
balanced view of organisational performance without
overwhelming managers with data or overburdening
their organisation with reporting requirements. The aim
of producing a small but balanced set of indicators to
support strategic decision-making has given rise in
recent years to the idea of “dashboards” [7]. The pur-
pose of a dashboard is to present a small set of perfor-
mance measures on a regular and structured basis to
strategic decision-makers. These performance indicators
should focus attention on activities of greatest impor-
tance to an organisation and its stakeholders, thereby
minimising the data collection burden.
The construction of a dashboard requires a full under-
standing of the operation of the organisation and the
collaboration of its employees. A dashboard requires the
creation of an optimal list of metrics from a large pool
of potential indicators in a way that makes sense to
those delivering services, as well as to strategic manage-
ment and wider stakeholders. Put formally, the informa-
tion architecture of a good dashboard will optimise the
efficiency of an organisation’s performance monitoring
systems.
Performance monitoring and evaluation of national
health research systems
As governments have grasped the concept of national
health research systems, some have attempted to take
more strategic approaches to manage these systems for
national benefit. Increased investment in research for
health has been accompanied by increased interest in
how this money is spent and what it achieves [8].
Governments such as those in Canada [9], Singapore
[10] and Australia [11] have sought to consolidate pre-
viously disparate elements of their health research activ-
ities into cohesively managed systems, often with unified
funding streams and lines of accountability. Whilst there
have been attempts to develop conceptual frameworks
for evaluating the functioning of national health
research systems [12] and the economic contribution of
research and development [13], none of these has
addressed how to monitor prospectively the perfor-
mance of health research systems. There have also been
attempts to produce ‘snapshot’ assessments of the capa-
cities and capabilities of various national health research
systems [14,15]. These analyses were not, however,
designed to be part of a continuous process of data col-
lation and analysis that might inform management of
the systems.
Thus, the combination of increased public funding for
health research, growing political attention on national
health research systems, and a paucity of empirically
tested frameworks for performance monitoring of
investments in such systems has created a challenge for
governments seeking to strategically strengthen health
research systems for national health, social and eco-
nomic benefit.
The National Institute for Health Research
In January 2006 the Government of the United King-
dom launched its health research strategy, Best Research
for Best Health [16]. The National Institute for Health
Research (NIHR) was established in April 2006 under
the management of the Department of Health as the
main mechanism for delivering the vision, mission and
goals of the strategy. Working in concert with other
health research funders, (particularly the UK Medical
Research Council and members of the UK Clinical
Research Collaboration), NIHR adopted a central role in
creating and optimising an applied health research sys-
tem embedded within the English National Health Ser-
vice (NHS). Through a diverse investment programme
NIHR sought to create a critical link between the health
and health research systems in England.
In June 2006, NIHR published its plans for delivering
a broad programme of initiatives designed to achieve
the objectives of Best Research for Best Health.N I H R
initially published sixteen implementation plans grouped
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plan described a specific programme of activity designed
to deliver a specific objective of Best Research for Best
Health. Examples included plans to establish biomedical
research units in health-research areas of unmet need
and plans to build research workforce capacity through
the creation of new training programmes.
Explicit within Best Research for Best Health was a
commitment by the UK Government to “implement
methods of evaluating the equality and effectiveness of ...
capacity, infrastructure and direct funding“. The strategy
also stated that “all elements of the new strategy will
operate under clear and robust management arrange-
ments supported by programmes of evaluation“.T h e s e
commitments, taken together with pre-existing UK Gov-
ernment policy on performance management of public
sector delivery [17] and health research in particular
[18], set a clear requirement for NIHR to develop and
implement a cogent approach for monitoring and evalu-
ating its activities and performance.
Our work aimed to develop and implement a frame-
work for defining key performance indicators that would
allow NIHR to meet its reporting requirements and
build its monitoring and evaluation capability.
Methods
Between February 2007 and June 2009 we developed
and piloted a framework for defining performance indi-
cators for the National Institute for Health Research in
England. To be acceptable to NIHR, our framework
needed to address the inherent challenges of measuring
performance in health research, namely: the long lead
time between investment activity (inputs) and return on
investment (outputs and outcomes) associated with
health research; the non-linearity of the research pro-
cess; and the effect that these factors have on attributing
outcomes [19-21]. The framework also needed to allow
NIHR to discharge its reporting duties in line with the
commitments made in the UK Government health
research strategy (Appendix 2), and we wanted to
ensure compliance with FABRIC [17], a best practice
framework for performance information systems devel-
oped by the UK Government.
Development of conceptual framework
A review of relevant peer-reviewed and grey literature
revealed no performance monitoring frameworks that
met the specifications set. As a result, we opted to cre-
ate a novel conceptual framework by combining ele-
ments of two existing performance frameworks: the
logical frame (or log-frame) approach (LFA) and the
Balanced Scorecard (BSC).
From the log-frame approach we adopted the logic
model, simplified to inputs, processes, outputs and
outcomes. This enabled us to address the challenge of
tracking the longitudinal relationship between investment,
system activities and system outcomes over longer time-
periods. From the BSC we adopted the three domains of
performance monitoring that were relevant to NIHR
(financial performance, internal processes and interactions
with external parties), which enabled us to take account of
the non-linear interdependencies of the research process.
The ‘learning and growth’ domain proposed in Kaplan
and Norton’s original balanced scorecard was not for-
mally incorporated into our framework for two reasons.
First, we developed our framework when NIHR was in
its initial growth phase, during which time it was
launching and establishing multiple new initiatives. The
progress of this foundation process was already being
monitored through the publication and regular updating
of NIHR’s implementation plans. In the presence of this
milestone reporting, it was felt that any new indicators
would be likely to simply restate already reported levels
of performance in this domain. Second, the research
workforce capacity development activities of NIHR (an
important area of activity that might typically be repre-
sented in the learning and growth domain) were already
represented in a specific implementation plan. As a
result, we judged that performance in this area would be
sufficiently captured through the development of appro-
priate financial, internal and external performance indi-
cators, as proposed in our framework.
By combining the logic model structure with the three
BSC domains we were able to produce a structure for
defining a dashboard of performance indicators (Figure
1) with the potential to improve attribution of health
research system outcomes.
This dashboard structure was used to create a series
of dashboard framework templates or ‘dash-cards’
(Figure 2) that could be completed by managers for
each of NIHR’s implementation plans. These templates
included aims, deliverables, metrics and reporting fre-
quencies for each of the logic model stages in each of
the three Balanced Scorecard domains. Our intention
was to cascade the performance indicators from these
programme-specific dashboards into a system-wide
dashboard of indicators (Figure 3), allowing for compre-
hensive coverage of all relevant research system activity
- whilst also creating bespoke performance reports for
each of NIHR’s programmes of work.
Stakeholder validation and piloting
Following its initial development we validated the con-
ceptual framework through a series of semi-structured
interviews and focus groups with key senior stakeholders
within NIHR. We used a “suitability, feasibility, accept-
ability” approach to assess stakeholders’ perceptions of
the framework’s suitability (fitness for purpose),
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ted) and acceptability to important stakeholder groups
(including researchers, research administrators and
research users). We began by presenting the framework
in individual interviews with four (out of seven) senior
managers from the Department of Health’s Research
and Development Directorate’s Senior Management
Team. Following feedback from these managers we pre-
sented an updated framework to members of the NIHR
Advisory Board, who were invited to comment on its
feasibility, suitability and acceptability. We then under-
took nine focus groups, conducted in parallel at an away
day involving all members of the Research and Develop-
ment Directorate at the Department of Health. These
focus groups allowed us to canvas the opinions of all
health research system managers responsible for the
implementation of NIHR’s operating strategy.
Following the stakeholder feedback outlined above, the
framework was piloted across one of NIHR’sf o u rm a i n
divisions (National Research Programmes). The piloting
exercise allowed us to assess the practicality of applying
the framework more widely.
Wider application of conceptual framework across health
research system
Managers with direct responsibility for delivering
NIHR’s implementation plans were subsequently asked
to develop performance indicators by completing dash-
cards for the plans they were responsible for.
We encouraged indicators to be developed in consul-
tation with the teams responsible for delivering each
implementation plan, including contractors and colla-
borators from outside the Department of Health and
NIHR family. This engagement represented the ‘bottom-
up’ aspect of our approach. Its aim was for managers
and delivery teams to identify ‘ideal’ performance indica-
tors for each implementation plan, creating a dashboard
of indicators for each work-stream.
Training in completing the dash-cards was provided
through the provision of a single workshop to which all
implementation leads were invited, supplemented by
written instructions to implementation leads. Submitted
dash-cards were then reviewed by members of the pro-
ject team (JG, MH, and AET) and re-iterated with
implantation leads where they had requested assistance
Inputs Process Outputs Outcomes
Logic model Balanced scorecard
–F i n a n c i a l
– Internal processes
–U s e r  s a t i s f a c t i o n
– Learning & growth
Integrated ‘Dashboard’ Approach
Inputs Process Outputs Outcomes
Financial
Internal
External
Aim Key
deliverableMetric
Figure 1 Integrated dashboard structure.
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support was provided to implementation leads where
they specifically requested assistance from the project
team in applying the conceptual framework to their
implementation plans.
Information architecture of system-wide performance
monitoring framework
It was our intention that work-stream specific dash-
boards would form the basis of a wider NIHR
performance monitoring framework, with indicators
from these dashboards underpinning the development
of two distinct performance reports: the NIHR-wide
Dashboard and the NIHR Outputs Framework (as
shown in Figure 3).
The system-wide dashboard was designed to act as an
internal management tool, providing the Department of
Health’s Research and Development Directorate with a
periodic overview of the performance of NIHR’sc o n s t i -
tuent programmes to guide short term (i.e. quarterly)
Figure 2 NIHR dashboard framework template.
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report would be populated by programme management
indicators derived primarily from work-stream input,
process and output indicators, which by their nature
relate more readily to early phase system activity.
A separate NIHR Outputs Framework was proposed
for external publication to facilitate strategic review and
public accountability. It was planned that this report
would combine selected output and outcome perfor-
mance metrics (strategic management indicators) with
monitoring information and other modalities of evalua-
tion (e.g. structured case study reports and commis-
sioned external reviews of implementation and impact)
to provide a more strategic perspective on NIHR’sp r o -
gress in achieving its over-arching goals. Our work
sought to contribute to the development of this strategic
performance report by providing metrics and a broader
performance information architecture. The work to
develop this report was, however, formally incorporated
into NIHR’s evaluation framework and thus is not dis-
cussed here.
Development of a system-wide performance dashboard
Following completion of the work-stream dashboards we
compiled a long-list of all proposed metrics and the
information required to construct these metrics (meta-
data), including their reporting frequency. We then
applied a process of aggregation, compounding and
selection to create a short-list of thirty metrics as key
indicators that might contribute to an NIHR-wide over-
sight dashboard. This process followed the principles of:
aggregating compatible metrics wherever this was mean-
ingful (e.g. all research programmes had proposed mea-
sures relating to the percentage of programme funding
that had been successfully disbursed within a given time
period); compounding commonly proposed metrics to
NIHR
Outputs
Framework
NIHR
Dashboard
‘Upward cascade’ of implementation 
plans for NIHR Dashboard
Monitoring
information
Programme Management
Domain
Strategic Management
Domain
Dashboards  for each 
implementation plan
Inputs Process Outputs Outcomes
Financial
Internal
External
Aim
Key
deliverable Metric
Synthesis of 
(selected) External 
/Output (and 
Outcome) / External 
metrics 
Figure 3 Conceptual approach for developing performance monitoring framework.
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per unit measures); and selecting specific indicators for
promotion to the NIHR-wide short-list where a measure
was considered to be critical to the delivery of one of
NIHR’s strategic goals (e.g. total number of researchers
a n dt r a i n e e ss u p p o r t e db yN I H R ) .A tt h i ss t a g ew ed i d
not exclude indicators that were only reportable at
intervals greater than 6 months however frequency of
indicator reporting was a key consideration in selecting
the final dashboard indicators.
These thirty indicators were then presented to the
NIHR senior management team who identified, through
a process of discussion-based consensus, what they felt
were the most appropriate measures for quarterly
review. This engagement represented the ‘top-down’
aspect of our approach and resulted in fifteen indicators
being selected. Given that the aim of the dashboard was
to support operational decision making by NIHR, the
final short-list of measures was also informed by the
need to choose only indicators that could be meaning-
fully reported on a quarterly basis. To quality assure our
selection, we again assessed the shortlisted indicators
against the FABRIC criteria to ensure the proposed per-
formance monitoring framework was focused, appropri-
ate, balanced, robust, integrated and cost effective [17].
Mechanisms were subsequently proposed for the col-
lation and reporting to the NIHR senior management
team of these high-level indicators (organised by strate-
gic goal) over a pilot period of twelve months.
Results
In mid-2007, when we first developed the NIHR dash-
board framework, eighteen implementation plans had
been published. Following consultation with NIHR
senior managers, it was determined that sixteen of these
plans were suitable for our framework. The excluded
implementation plans were one-off initiatives that would
not produce performance information on an ongoing
basis: namely, the high-level descriptive plan for estab-
lishing the governance for NIHR and the plan governing
transitioning of funding arrangements for NHS research
from the pre-NIHR system. Over the lifetime of our
work (up to June 2009) NIHR evolved its implementa-
tion strategy, resulting in an increase in the number of
implementation plans to forty-three, of which thirty
were active in the last six months of our work.
The conceptual framework and indicator development
templates were well received by NIHR’ss e n i o rm a n a g e -
ment team, the NIHR advisory board and the Depart-
ment of Health’s Research and Development directorate.
All groups endorsed the approach for piloting. The pilot
of the implementation of the framework demonstrated a
high degree of user acceptability, with all operational
managers able to complete the templates and iterate
proposed indicators in line with the FABRIC principles.
The piloting process demonstrated that the conceptual
framework could be readily applied by managers in
NIHR’s health research system. It also provided practical
experience on applying the framework that could be
passed on to other NIHR managers involved in the next
stage of implementation.
Completed indicator development templates were
received for twenty-four out of thirty work-stream man-
agers within six months of distribution. The twenty-four
templates identified exactly two-hundred and fifty differ-
ent metrics (Table 1).
Following our process of compounding, aggregation
and selection, this long-list of 250 potential metrics was
reduced to a shortlist of thirty potential metrics grouped
into sixteen categories (Figure 4). Following involvement
of the NIHR senior management team, fifteen indicators
were selected for initial piloting in an NIHR-wide over-
sight dashboard (Table 2, Table 3). Consensus was read-
i l ya c h i e v e db yt h eN I H Rsenior management team
around which indicators should be piloted, aided signifi-
cantly by reassurances that senior managers would be
able to re-iterate the constitution of the dashboard over
a period of not less than nine months.
In addition to the production of a suite of indicators
suitable for adoption in a system-wide dashboard, the
process of developing and implementing our perfor-
mance monitoring framework contributed directly to
the development of a NIHR performance information
system and led to the establishment of an executive
position within NIHR of a Head of Business Intelligence.
Discussion
Rationale for developing a novel framework
In developing our framework our aim was to produce a
system for defining performance indicators that would
allow managers to monitor the performance of their
health research system in an effective and timely man-
ner. We wished to ensure that the set of these indicators
was broad enough to provide a balanced perspective of
performance, whilst being focused enough that man-
agers felt able to draw insights of use in day-to-day
management without suffering information overload.
There is a growing body of work proposing
approaches to the evaluation of health research systems
Table 1 Number of proposed long-list metrics by logic-
model stage and modified balanced scorecard domain
Input Process Output Outcome Total
Financial 20 17 17 16 70
Internal 29 25 23 10 87
External 17 23 36 17 93
Total 66 65 76 43 250
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few of these approaches had been applied empirically.
Furthermore, none of the approaches we encountered
addressed the needs of health research system managers
and policy-makers by providing a mechanism for pro-
spective monitoring of the performance of health
research systems. Specifically, our literature review
retrieved no performance monitoring frameworks that
had been applied to health research agencies with a
s c o p eo fr e s p o n s i b i l i t yc o m p a r a b l et oN I H R .W et h u s
felt it necessary to develop a novel framework.
Design of our framework and relationship to previous
work
Basing our framework on two well-established and com-
plementary performance monitoring frameworks allowed
us to draw key strengths from both. The use of logic
models is not controversial, having been widely prac-
ticed for over twenty years in many settings, and their
use and benefits in shaping systems for evaluating the
impacts of health research have been well described
[22-24]. Their potential for providing a prospective fra-
mework for monitoring performance in health research
systems had not, however, been previously explored. By
monitoring resources, activities and effects throughout
the logic chain we sought to create a balanced picture
of performance across the chain of system activities over
time. Such a longitudinal perspective is especially impor-
tant when assessing performance in research activity,
where the lag time between investment and outcome
can be extensive [25]. A longitudinal perspective is also
useful in providing a basis for observing and under-
standing the relationship between upstream research
Applications
• Number of applications
• % of applications considered 
viable
• % of applications funded
Disbursement
• % of planned expenditure 
disbursed
Overheads
• % of total cost of programme 
spent on operations
Cost per output
• Cost per publication
• Cost per participant recruited 
into clinical research
• Cost per trainee
Financial governance
• Expenditure audited and 
signed off by NIHR
Timeliness
• % of funding decisions made 
within target time period
Networks
• % of networks achieving 
targets / milestones set out in 
proposals
• Number of people 
participating in NIHR trials
• % of NIHR-linked trials within 
5% of recruitment plan
Reputation
• NIHR reputation/satisfaction 
surveys:
-NHS
-Academics (incl. Faculty)
-Industry
-Patients and public
Completion
• % of research projects 
completed to plan
• £s spent on project 
extensions
Quality
• Bibliometric data for NIHR 
programmes, including: 
Number of peer reviewed 
papers; Number of peer 
reviewed outputs; citations to 
the above
Impact
• Major research achievements 
that have the potential to 
improve health and social 
care – highlights and 
milestones
Attention
• Number of parliamentary 
questions relating to NIHR
• NIHR-related news stories in 
the national media
Bureaucracy
• Average time for decision by 
research ethics committees
• Number of research 
passports active
• Pages accessed through 
NIHR portal
Corporate and risk reporting
• Corporate business metrics 
not otherwise covered 
(currently being defined with 
DH)
• Issues escalated for 
monitoring by NIHR Senior 
Management Team
People
• Number of Faculty members 
at each level
• Number of researchers  
supported by flexibility and 
sustainability funding
• % trainees completing 
research training
Industry
• Number of industry funded 
trials taking place through 
NIHR networks
• Average value of industry 
funded NHS trials
Figure 4 Short-list of performance indicators considered for NIHR-dashboard.
Table 2 Number of indicators initially piloted for NIHR-
wide oversight dashboard (June 2009) by logic-model
stage and modified balanced scorecard domain
Input Process Output Outcome Total
Financial -1 2 - 3
Internal 13 1 - 5
External 11 4 1 7
Total 2 5 7 1 15
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changes (outcomes and impacts such as change in
population health status).
Our decision to combine the logic chain with a modified
balanced scorecard was born out of a desire to ensure that
our framework encouraged a balanced view of research
system activity ‘cross-sectionally’ as well as longitudinally.
By this we mean that we wanted to make sure that indica-
tors reflecting the variety of domains of research system
activity, (such as financing, research governance and
managing external relationships), were also included.
The influence of framework design and management
preference in indicator selection
The final set of performance measures selected for pilot-
ing in the NIHR oversight dashboard demonstrated the
effects of two distinct developmental influences:
1) the effect of applying our conceptual framework
to the operational plans of a health research system;
and
2) the effect of existing performance reporting
mechanisms and managerial preferences on the
selection, balance and overall character of perfor-
mance information.
That both the long-list of potential metrics and the
final pilot indicators span the full range of logic-model
stages and balanced scorecard domains demonstrates
the breadth and balance that applying our hybridised
framework can achieve. On the other hand, the particu-
lar mix of indicators selected to populate the NIHR
oversight dashboard demonstrates the focus of senior
managers on external and early phase effects of research
system activity. In general, the indicators are early phase
(input, process and output), in response to the prospec-
tive reporting needs of managers and the desire for
close monitoring of performance (in this case quarterly).
The relative lack of financial indicators in the pilot over-
sight dashboard relates primarily to the existence of
alternative financial reporting mechanisms within the
Table 3 Indicators initially piloted for NIHR-wide oversight dashboard (June 2009)
Strategic goal Indicators BSC
domain
Logic
model
stage
Goal 1: Establish the NHS as an internationally
recognised centre of research excellence
Number of applications to NIHR Faculty and Research programmes External Input
Number of industry funded trials taking place through NIHR
networks and experimental medicine research facilities
External Process
Total value of industry funded trials taking place in the NHS External Output
% of NIHR-portfolio trials achieving greater than 95% of recruitment
plan
Internal Process
Number and favourability of news stories relating to NIHR and NHS
research in national and international media each month
External Output
Goal 2: Attract, develop and retain the best research
professionals to conduct people-based research
Number of faculty members at each level of NIHR Faculty
(Investigators, Trainees and Associates)
Internal Process
% of personal award scheme (research fellowship) applicants
coming from university departments rated as excellent in the 2008
UK Research Assessment Exercise
External Outcome
Goal 3: Commission research focused on improving
health and care
% of planned research expenditure disbursed Financial Output
% of applications for research grants deemed fundable that were
funded
Financial Process
Number of new publications that attribute NIHR funding deposited
on UK PubMed Central each month and % of these in journals
targeted at practitioners
External Output
Goal 4: Strengthen and streamline systems for
research management and governance
Average time from commission to commencement of NIHR-
portfolio studies
Internal Process
Number of research passports active Internal Output
Pages accessed through the NIHR portal and website External Output
Goal 5: Act as sound custodians of public money
for public good
% of total cost of programme funding spent on research
administration
Financial Process
Number of risk register issues escalated for monitoring by NIHR
Senior Management Team
Internal Input
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for expenditure through NIHR.
Engagement of health research system managers in
design and implementation of performance monitoring
frameworks
In many government systems, health research system
managers are increasingly being asked to take significant
responsibility for the efficiency and effectiveness of
national research efforts. Yet often they find themselves
managing these systems with a paucity of appropriate
performance information. As the end-users of such per-
formance information, it is important that they are
involved in the selection and design of reporting
mechanisms for such information. Our review of the
publicly accessible literature on performance monitoring
and evaluation of health research systems suggests that
such involvement is not a hallmark of work in this field
to date.
Although our engagement with managers and policy-
makers in the English Department of Health and NIHR
might have been more extensive - for example by
undertaking additional cycles of iteration of proposed
indicators with implementation plan managers - we still
feel that it played a critical role in shaping the outcome
of our work, both in terms of the indicators proposed
and selected, and in terms of the acceptance of these
performance indicators.
Impact of stakeholder mix on development and selection
of performance indicators
In developing and piloting our framework, we encour-
aged the involvement of stakeholders from the wider
health research system by inviting implementation plan
l e a d st oi n v o l v eo t h e rc o n s t i t u e n t sa st h e yf e l ta p p r o p r i -
ate. Three factors influenced our decision to employ this
‘cascade’ approach to involvement. First, we felt that such
involvement might help broaden consensus on the devel-
opment of specific indicators with those individuals who
would ultimately be performance managed in light of
these indicators; (primarily, health research system man-
agers). Second there was a pragmatic need to engage
across a large organisation and stakeholder pool quickly
with limited resources. Finally, we felt that health
research system managers responsible for delivering indi-
vidual implementation plans were better placed than us
to identify which stakeholder groups could best comment
on the development of programme specific metrics.
We hoped that stakeholders such as researchers,
health system managers, clinicians and patient groups
would become involved where appropriate, however we
intentionally did not seek to mandate directly the speci-
fic involvement of any particular group. The net effect
of our cascade approach was that the voices of
researchers, clinicians, health system managers and citi-
zens were only present in discussions around the devel-
opment of particular metrics when such stakeholders
were already embedded organisationally within NIHR
structures.
Whilst the mix of stakeholders involved was skewed
towards health research system managers, we do not
believe that this mix had a substantive effect on the type
of indicators ultimately selected for the NIHR-wide
quarterly performance dashboard in terms of their logic
model stage. As noted previously, the mix of indicators
piloted in the NIHR-wide dashboard consisted mainly of
process and output indicators (such as the number of
individuals supported by NIHR Faculty funding or the
number of industry funded trials supported by NIHR
infrastructure funding). This balance of indicators prob-
ably reflected the need to create a prospective perfor-
mance report that would guide short-to-medium term
(quarter-to-quarter) decision making. Given this context,
it was always expected that programme management
indicators would predominate this report. It was
intended that strategic indicators of performance, such
as changes in health service practice or improvements
to population health, would be captured by the NIHR
Outputs Framework (Figure 3).
Although we hypothesise that stakeholder mix did not
significantly influence logic model stage prevalence in
the final system-wide dashboard, it may be that external
stakeholders would have placed greater emphasis on
selecting indicators belonging to the external balanced
scorecard domain. It is worth noting, however, that of
the fifteen indicators proposed for piloting in the NIHR-
wide dashboard, nearly half (seven) were from the exter-
nal BSC domain, compared with three financial and five
internal.
Another important question is whether involving a
different mix of stakeholders in developing indicators
would have produced a substantively different result in
terms of the specific detail of proposed indicators. It
could be hypothesised that greater involvement of
research users (healthcare managers and clinicians for
example) or intended beneficiaries of research (e.g.
patients, tax-payers) might have led to a greater focus
on indicators relevant to health system outcomes.
Although we cannot be sure, we strongly suspect that
changing the stakeholder mix at the point of indicator
development would not have had a direct impact on the
range and nature of proposed indicators. We assert this
because the strategic focus for indicator development
(the goals and priorities against which performance
would need to be measured), had already been estab-
lished in a national health research strategy [16] and
encapsulated operationally in NIHR’s implementation
plans (Appendix 1). Any individual applying our
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development on the objectives and plans set out in the
implementation plans, limiting their capacity to substan-
tially redefine the focus of performance assessment.
It is conceivable that broader involvement of stake-
holders beyond health research managers might have
indirectly affected indicator development, if such engage-
ment led to NIHR altering its operational intent and thus
amending its implementation plans. For this to have taken
place, however, we postulate that significant dissonance
would have been needed between the priorities of stake-
holders and the strategic priorities set out in the national
health research strategy for England [16]. We feel that it is
unlikely that such extensive dissonance existed the time of
our work, given that the English health research strategy
had been informed by a broad consultative process [26] -
and, as noted by Hanney and colleagues, “the overall direc-
tion of the proposed new strategy received considerable
support during the consultation” [27].
Whilst we feel that the involvement of different stake-
holders might not have substantively changed the nature
of indicators ultimately selected for the system-wide
performance dashboard, we are aware that it may have
affected the perceived validity of the structure and out-
puts of our framework. It may be that in time, a per-
ceived lack of engagement of certain stakeholder groups
(such as researchers or clinicians) may undermine the
credibility of the approach to performance monitoring
by these and other groups. Factors mitigating against
this are the involvement of these groups in the develop-
ment of the antecedent health research strategy, and the
previously mentioned existence of individuals from
these stakeholder groups within the operational infra-
structure of NIHR.
In other health research systems the mix of stake-
holders involved in the indicator development process
may well have a more significant effect on the final out-
put of such a process than we have postulated was the
case with NIHR. In contexts where strategic planning of
a health research system has been less consultative or
has not explicitly occurred (e.g. where a system has
developed incrementally through the evolution of pre-
existing components into a single system under com-
mon oversight without a specific restatement of strategic
intent such as a national strategy on research for
health), broadening the mix of stakeholders involved in
the indicator development process may well have a sig-
nificant and beneficial effect on both the development
of performance indicators as well as the development of
consensus around system function.
Impact on organisational decision making
The scope of this phase of our work was to develop and
apply a conceptual framework for defining appropriate
key performance indicators for NIHR. As such, it did
not extend to monitoring the impact of the dashboard
on organisational decision making beyond this develop-
ment phase. Nor did it extend to monitoring the itera-
tion of the dashboard and performance reporting system
that we expected to occur over time. We hope that in
time the experiences of NIHR in applying and refining
the dashboard as a system-wide performance assessment
tool will be made available to inform the work of others.
Our work did, however, have tangible effects on the
organisational development of NIHR. These included
informing the specifications of NIHR’s performance
information systems, and the creation of a formal posi-
tion within NIHR for a Head of Business Intelligence,
with responsibility for managing NIHR’s performance
monitoring and evaluation function.
Proportionality and focus of our approach
As highlighted in Appendix 2, an important criterion for
our work was that it had to balance the benefits of col-
lating performance information against the costs (trans-
action and opportunity costs) of reporting. It was our
initial intention to develop a prospective performance
report (i.e. system-wide dashboard) that could provide a
balanced ‘at-a-glance’ perspective of health research sys-
tem performance, whilst also limiting reporting burden
to the minimum necessary level to support such a
report. To this end, we can claim some success, in so
much as our final proposed dashboard consisted of only
fifteen indicators to oversee the activity of a health
research system with an annual budget in 2007 of £859
m (US$1.7bn in 2007) [28]. Furthermore, our dashcard-
based development process instilled a consistent infor-
mation architecture in the definition of performance
indicators across all of NIHR’s activities, the net effect
of which was to allow the rapid formulation of perfor-
mance dashboards at any organisational level that might
be required.
In order to fully demonstrate that our performance
information architecture was truly proportionate, how-
ever, we need to not only demonstrate that the asso-
ciated reporting burden was low and reporting activity
appropriately focused, but also that the overall perfor-
mance monitoring system was still effective. As high-
lighted above, we are not currently in a position to
comment on the success or otherwise of the system-
wide dashboard in enhancing system performance, but
we are eager for this insight to become available in time.
In terms of demonstrating that our approach resulted
in the development of an appropriately focused set of
indicators, we can draw some encouragement from the
fact that indicators for the system wide dashboard could
be readily mapped each of NIHR’s five strategic goals
(Table 3). We also feel that it is encouraging that these
El Turabi et al. Health Research Policy and Systems 2011, 9:13
http://www.health-policy-systems.com/content/9/1/13
Page 11 of 15indicators spanned all of the balanced scorecard and
logic model domains and received assent from the
NIHR senior management team for piloting. Again,
though, definitive conclusions regarding the focus and
balance of indicators proposed can only be made by
studying experiences of using the dashboard over a per-
iod of time.
Implications for institutional learning
As noted above, our framework omits the learning and
growth dimension of the balanced scorecard - and there
were good reasons for such an omission. Nevertheless, it
may be useful to represent learning processes if such a
framework is applied more widely. The effectiveness of
stewardship of a health research system is likely to be
impaired if the overseeing organisation is ineffective at
collating and analysing the consequences of its actions.
While the organisation may have a clear grasp of the
outputs of the health research system, it will be unsure
how its actions contributed to these outputs; to use the
well-known terminology of Agryis and Schon, ‘single
loop’ learning will be present, but ‘double loop’ learning
will be absent [29].
The creation of a framework in isolation is unlikely to
generate such learning - or to trigger effective perfor-
mance management as such. The organisation in ques-
tion must also have the ability to comprehend, reframe
and act on the information provided by the framework.
This ability, or ‘absorptive capacity’, may be created by a
combination of substantive knowledge, organisational
culture and directed leadership [30]. For reasons
explained above, our work with the NIHR was not
accompanied by attempts to develop such absorptive
capacity, yet they are likely to contribute significantly to
the successful implementation of performance monitor-
ing frameworks.
Risks associated with our approach and process lessons
learned
The risks associated with our approach for developing
performance indicators fall into two categories: 1) those
generic risks associated with the development of perfor-
mance indicators for any system (e.g. perverse incentivi-
sation, loss of rich narrative, etc.); and 2) those risks
that occur specifically as a result of applying our parti-
cular method of indicator development.
A number of generic challenges (i.e. those not peculiar
to the implementation of our framework) face any actor
attempting to define performance indicators for a health
research system. We believe that foremost amongst
these is ensuring that there is sufficient agreement on,
and articulation of, the strategic intent of the health
research system. Without clarity around the aims and
objectives of a health research system, it is impossible to
meaningfully measure progress towards the achievement
of the system’s goals. Although we accept that this state-
ment is true of developing performance information for
any system, our experiences of working with health
research organisations and systems indicates that lack of
strategic clarity remains a critical barrier to higher qual-
ity performance monitoring systems. Indeed, often the
development of performance monitoring frameworks
can highlight areas of strategic inconsistency (e.g. state-
ments of strategic intent unsupported by programmes of
activity or programmes of activity that do not correlate
to any strategic goals). Although this was not our
experience of working with NIHR, we believe that the
link between strategy and performance monitoring fra-
meworks represents the greatest vulnerability to those
seeking to develop effective performance indicators.
This risk does, however, pose a particular challenge to
anyone wishing to apply our framework in a different
context. Given that our entire approach is predicated on
the assumption that a coherent and broadly supported
health research system strategy already exists before our
framework can be applied, it may be difficult (but by no
means impossible) for others seeking to replicate our
work in less mature health research systems to achieve
comparable results. In such a scenario, it would be
important for the process of developing a performance
management framework to be intimately linked with the
process of developing and refining a system strategy.
The second major generic challenge relates to mana-
ging the risks associated with specific indicator develop-
ment, most critically the risk of creating perverse
incentives that skew behaviour of those whose perfor-
mance is being assessed in a manner not predicted or
desired by those responsible for defining performance
measures. Once indicators themselves become the focus
of behaviour they may disrupt rather than enhance per-
formance. To some degree this risk comes about as a
result of the inherently abstractive nature of perfor-
mance indicators. However, the risk can be reduced by
ensuring that performance is interpreted in the context
of a balanced set of indicators. The use of a framework
for quality assuring the performance indicator develop-
ment process (such as the FABRIC approach utilised in
our approach), combined with a commitment to peri-
odic review and iteration of performance indicators with
stakeholders, can go some way to reducing the risk of
perverse incentives. We would thus strongly recommend
that the adoption of such practices be considered an
essential component of any programme to develop a
performance monitoring framework for health research
systems.
The final generic challenge relates to managing the
‘social’ threat posed to those who might be held accoun-
table by new models of performance information.
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of performance painted by a set of performance indica-
tors will always be an abstraction of real performance,
and as such will always be subject to the vagaries of
incomplete assessment, sampling error and injudicious
interpretation. Nonetheless, the intent when producing
performance information is to provide insight that will
help guide management (i.e. resource allocation includ-
ing the allocation of incentives and sanctions). The
intellectual limitations of a performance monitoring
methodology carry real world consequences to the bene-
ficiaries of the system under consideration. In the con-
text of health research systems, the development of
inappropriate performance indicators can have profound
impacts upon those regulating, commissioning, conduct-
ing and interpreting research. Concern that inappropri-
ate measures may be developed or that measures will be
used injudiciously can create significant organisational
resistance to the development and implementation of
new performance indicators.
In addition to the generic challenges facing those
seeking to develop performance indicators for health
research systems, we believe that there are some specific
challenges associated with implementing our particular
framework. The greatest challenge we faced in imple-
mentation (one we failed to fully appreciate and miti-
gate) was the need to provide appropriate ongoing
dialogue and support between the project team and the
health research system managers tasked with developing
indicators for each implementation plan.
We had identified lack of ‘buy-in’ from implementa-
tion plan managers as a key risk to the successful appli-
cation of our framework within NIHR. We had also
anticipated that a novel approach to developing perfor-
mance indicators would require a greater degree of
implementation support than might be expected, had
we chosen to implement a framework that was more
widely recognised (e.g. a classic balanced scorecard
approach). As a result, we provided a training workshop,
written instruction and additional support, which led to
a number of presentations to operational units to guide
the development of implementation plan dash-cards. In
spite of these efforts, we were not able to meet with all
managers and teams that were ultimately asked to devel-
oped indicators.
In retrospect, this failure of communication on our
part may have played a significant role in limiting the
response rates to our dissemination of the indicator
development templates following the initial piloting of
dash-cards. It is likely that some health research system
managers did not feel comfortable with applying the
conceptual framework to their implementation plans (a
lack of ‘skill’) and/or were not convinced of the benefits
of utilising our hybrid framework and subsequent
information architecture (a lack of ‘will’), which may
have lowered submission rates of performance dash-
cards.
Were we to repeat this exercise, we would pay greater
attention to the manner in which we advocated our spe-
cific approach to developing performance indicators,
and we would prioritise project resources to provide a
more comprehensive communications and implementa-
tion support function.
Conclusions
Whilst our work represents only a modest development
in conceptual frameworks for performance monitoring,
its successful pilot adoption and implementation pro-
vides some empirical experience on how theories of per-
formance monitoring for health research might translate
into practice. Our framework will be of interest to
others seeking to develop performance indicators for
health research systems, especially at the national and
international levels. Although the specifications set for
developing our framework were formally based on a fra-
mework developed by the UK government, we feel that
they are similar enough to the requirements of other
national health research funders as to render the frame-
work relevant to such funders.
Applying our methodology to other health research sys-
tems is likely to yield very different performance indicators
from those proposed for NIHR. For example, for other
research systems at different stages of maturity it may be
appropriate to incorporate all of Kaplan and Norton’s ori-
ginal BSC domains in the base framework. Similarly, dif-
ferent health research system managers may opt to select
a differing mix of indicators for high-level monitoring to
those selected by NIHR. This capacity for variation in the
specific outputs of applying our framework to different
systems is, we believe, entirely appropriate and a key
strength of the framework. The hybrid framework does
not attempt to provide a ‘cookie-cutter’ approach to
selecting performance indicators, but instead acts as an aid
that focuses the development of performance indicators
around the strategic objectives set by individual health
research systems. As with other performance monitoring
frameworks, this means that successful implementation is
dependent upon the clarity of strategic objectives set out
by a health research system; something that cannot always
be taken granted - as the history of health research policy
in England demonstrates [28].
In many government systems, health research system
managers are increasingly being asked to take significant
responsibility for the efficiency and effectiveness of
national research efforts. Unfortunately, they often find
themselves managing these systems with a paucity of
appropriate performance information. As the end-users of
such performance information, it is important that they
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indicators and reporting mechanisms.
The strengthening of the practice of performance mon-
itoring of health research systems will be important for
improving the impact that such systems have in meeting
national health and economic needs. In publishing our
methodology and results in this paper, it is our hope that
we might stimulate further commentary from academic
and practitioner communities and encourage others to
come forwards with their own experiences of perfor-
mance monitoring of health research systems. Greater
sharing of and learning from such practical experience is
an important stepping stone to creating performance
monitoring systems that can help bridge the gap in our
understanding of how health research system activities
relate to health research system impacts. Undoubtedly,
the academic disciplines of health services research, pub-
l i ch e a l t h ,p u b l i cs e c t o rp o l i c ya n dt h ee v a l u a t i o na n d
management sciences have much expertise to contribute
to this endeavour. Nevertheless, for academic insight to
have greatest impact, it will need to be tested practically
in partnership with policy-makers and managers respon-
sible for the operation of national health research sys-
tems. Empirical testing of this kind will slowly help
create a base of experience and evidence to inform ever
more useful performance monitoring approaches. This in
turn offers the promise of moving performance monitor-
ing and evaluation of health research systems from the
domain of advocacy to genuine performance manage-
ment for public gain.
Appendix 1: Best Research For Best Health
Implementation Plans - June 2006
The National Institute for Health Research
Implementation Plan 1.1 The National Institute for
Health Research
Implementation Plan 2.1 Funding transition
National Institute for Health Research Faculty
Implementation Plan 3.1 National Institute for Health
Research Faculty
Research systems and governance
Implementation Plan 4.1 Bureaucracy busting: Gov-
ernance, advice and ethics systems
Implementation Plan 4.2 Bureaucracy busting:
Research information systems
NHS research infrastructure
Implementation Plan 5.1 Clinical Research Network
for England
Implementation Plan 5.2 Clinical research facilities for
experimental medicine
Implementation Plan 5.3 Technology platforms
Implementation Plan 5.4 NIHR School for Primary
Care Research
NIHR projects, programmes, units and centres
Implementation Plan 6.1 Overview of NIHR research
projects, programmes, units and centres
Implementation Plan 6.2 Research for Patient Benefit
(RfPB) and Research for Innovation, Speculation and
Creativity (RISC) project schemes
Implementation Plan 6.3 Existing R&D programmes
Implementation Plan 6.4 Invention for Innovation
Programme
Implementation Plan 6.5 Programme grants for
applied research
Implementation Plan 6.6 Research units
Implementation Plan 6.7 Research centres
Appendix 2: Criteria for performance monitoring
and evaluation of NIHR
FABRIC properties of good systems of performance
information:
▪ Focused on the organisation’s aims and objectives;
▪ Appropriate to, and useful for, the stakeholders
who are likely to use it;
▪ Balanced, giving a picture of what the organisation
is doing, covering all significant
▪ areas of work;
▪ Robust in order to withstand organizational changes
or individuals leaving;
▪ Integrated into the organisation, being part of the
business planning and management processes;
▪ Cost Effective, balancing the benefits of the infor-
mation against the costs
FABRIC properties of good performance measures:
▪ Relevant to what the organisation is aiming to
achieve;
▪ able to Avoid perverse incentives - not encourage
unwanted or wasteful behaviour;
▪ Attributable - the activity measured must be cap-
able of being influenced by actions which can be attrib-
uted to the organisation, and it should be clear where
accountability lies;
▪ Well-defined - with a clear, unambiguous definition
so that data will be collected consistently, and the mea-
sure is easy to understand and use;
▪ Timely, producing data frequently enough to track
progress, and quickly enough for the data to still be
useful;
▪ Reliable - accurate enough for its intended use, and
responsive to change;
▪ Comparable with either past periods or similar pro-
grammes elsewhere; and
▪ Verifiable, with clear documentation behind it, so
that the processes which produce the measure can be
validated.
Commitments related to performance monitoring
and evaluation in ‘Best Research for Best Health’ -
the English National Health Research Strategy (2006)
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Page 14 of 15▪ “We will publish research performance data for
NHS Trusts relating to patient numbers, speed and
quality, to provide a source of information on reliability
on which to base judgements about the locations of
clinical trials.” (p12)
▪ “Monitor the advancement and assess the effects of
public involvement in NHS, social care and public
health research.” (p24)
▪ “Implement methods of evaluating the equality and
effectiveness of our capacity, infrastructure and direct
funding.” (p32)
▪ “All elements of the new strategy will operate under
clear and robust management arrangements supported
by programmes of evaluation, including ... regular review
of outputs, outcomes and value for money.” (p34)
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